Literature DB >> 8615823

Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.

E Kilgour1, I Gout, N G Anderson.   

Abstract

Pituitary growth hormone (GH) co-ordinately stimulates three distinct signalling pathways in 3T3-F442A preadipocytes, the STAT (signal transducer and activator of transcription) pathway, the mitogen-activated protein (MAP) kinase cascade and p70s6k. The mechanisms linking the GH receptor to these signals have not been fully identified. In this study we have examined the role of phosphoinositide 3-OH kinase (PI 3-kinase). Pretreatment of cells with wortmannin, a specific inhibitor of PI 3-kinase, prevented the activation of p70s6k and partially inhibited the activation of p42 and p44 MAP kinases by GH. In contrast, wortmannin failed to appreciably affect the GH-stimulated tyrosyl phosphorylation of JAK-2 or STAT-1. GH transiently increased the activity of PI 3-kinase recovered in antiphosphotyrosine immunoprecipitates. In addition, several tyrosyl-phosphorylated proteins were specifically adsorbed from lysates of cells exposed to GH by a glutathione S-transferase fusion protein containing the 85 kDa regulatory subunit of PI 3-kinase. GH also induced an increase in the PI 3-kinase activity associated with both JAK-2 and insulin receptor substrate-1 (IRS-1) immunoprecipitates. These results establish PI 3-kinase as an important mediator of GH signalling to the MAP kinase and p70s6k pathways and suggest that PI 3-kinase is activated by a mechanism involving JAK-2 and IRS-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615823      PMCID: PMC1217226          DOI: 10.1042/bj3150517

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

Review 1.  p70s6k/p85s6k: mechanism of activation and role in mitogenesis.

Authors:  S C Kozma; G Thomas
Journal:  Semin Cancer Biol       Date:  1994-08       Impact factor: 15.707

2.  A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase.

Authors:  R Woscholski; T Kodaki; M McKinnon; M D Waterfield; P J Parker
Journal:  FEBS Lett       Date:  1994-04-04       Impact factor: 4.124

Review 3.  Regulation of adipocyte development.

Authors:  P Cornelius; O A MacDougald; M D Lane
Journal:  Annu Rev Nutr       Date:  1994       Impact factor: 11.848

4.  Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase.

Authors:  T Okada; L Sakuma; Y Fukui; O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

5.  Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor.

Authors:  D J Meyer; G S Campbell; B H Cochran; L S Argetsinger; A C Larner; D S Finbloom; C Carter-Su; J Schwartz
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits.

Authors:  L Stephens; A Smrcka; F T Cooke; T R Jackson; P C Sternweis; P T Hawkins
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

7.  Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3.

Authors:  A Toker; M Meyer; K K Reddy; J R Falck; R Aneja; S Aneja; A Parra; D J Burns; L M Ballas; L C Cantley
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

8.  Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.

Authors:  J A VanderKuur; X Wang; L Zhang; G S Campbell; G Allevato; N Billestrup; G Norstedt; C Carter-Su
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

9.  Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.

Authors:  M Monfar; K P Lemon; T C Grammer; L Cheatham; J Chung; C J Vlahos; J Blenis
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

10.  Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis.

Authors:  E M Sale; P G Atkinson; G J Sale
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

View more
  11 in total

1.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

2.  Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase.

Authors:  M A Wilson; A R Burt; G Milligan; N G Anderson
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Growth hormone and phorbol esters require specific protein kinase C isoforms to activate mitogen-activated protein kinases in 3T3-F442A cells.

Authors:  S MacKenzie; I Fleming; M D Houslay; N G Anderson; E Kilgour
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

Review 5.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

6.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

7.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Authors:  Shoshana Yakar; Jennifer Setser; Hong Zhao; Bethel Stannard; Martin Haluzik; Vaida Glatt; Mary L Bouxsein; John J Kopchick; Derek LeRoith
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

8.  Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.

Authors:  Guolian Li; Juan-Pablo Del Rincon; Linda A Jahn; Yangsong Wu; Bruce Gaylinn; Michael O Thorner; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

9.  Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.

Authors:  Xiangdong Wang; Ning Yang; Luqin Deng; Xin Li; Jing Jiang; Yujun Gan; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2009-01-22

Review 10.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.